These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 4325139)
21. [Steroid therapy using ACTH or corticoids? Indications, effectiveness, and adverse effects of ACTH-therapy]. Hannemann HR Med Klin; 1974 Mar; 69(13):513-24. PubMed ID: 4364747 [No Abstract] [Full Text] [Related]
22. [Current perspectives in the control of bronchial asthma. Synacthen Depot]. Cardoso R Hospital (Rio J); 1969 Oct; 76(4):1439-54. PubMed ID: 4312092 [No Abstract] [Full Text] [Related]
23. [Therapy with ACTH (corticotropin)--unjustly neglected in Germany]. Gross F Internist (Berl); 1974 Jan; 15(1):52-4. PubMed ID: 4360019 [No Abstract] [Full Text] [Related]
24. [Adrenal cortex function in bronchial asthma or asthmatic syndromes treated with betamethasone dépôt (Diprophos)]. Piotrowska B; Droszcz W; Małunowicz E; Lech B Pneumonol Pol; 1981; 49(8-9):609-13. PubMed ID: 7301602 [No Abstract] [Full Text] [Related]
25. Assessment of long-acting synthetic corticotrophin in hypersensitive asthmatics and normal subjects. el-Shaboury AH Br Med J; 1968 Sep; 3(5619):653-5. PubMed ID: 4299775 [TBL] [Abstract][Full Text] [Related]
26. Severe reaction from tetracosactrin. Got A Med J Aust; 1972 Mar; 1(10):493. PubMed ID: 4337007 [No Abstract] [Full Text] [Related]
27. A controlled transfer from oral corticosteroids to corticotrophin in bronchial asthma. Cook MG; Donovan B Br J Clin Pract; 1971 Sep; 25(9):407-12. PubMed ID: 4329645 [No Abstract] [Full Text] [Related]
28. Pituitary-adrenal function in asthmatic patients treated with high dose of beclomethasone. Francia G; Senna GE; Betteli C; Musumeci C; Fratta-Pasini A; Piubello G; Gani F; Mezzelani P; Andri L Allerg Immunol (Paris); 1994 Jan; 26(1):11-5. PubMed ID: 8166935 [TBL] [Abstract][Full Text] [Related]
29. [Anaphylactic shock with fatal outcome after injection of synthetic corticotropin (Synacthen Depot) in a patient with severe asthma]. Abjörn C; Leonhardt T Lakartidningen; 1970 Sep; 67(39):4364-6. PubMed ID: 4319253 [No Abstract] [Full Text] [Related]
30. [Clinical trials with a new synthetic ACTH of prolonged action: Cortrosine Depot]. Libon JC; Borlée J Rev Bras Med; 1971 Apr; 28(4):185-7. PubMed ID: 4330569 [No Abstract] [Full Text] [Related]
31. [Therapy of chronic refractory skin diseases with synthetic ACTH, Cortrocin-depot]. Hayakawa M Hifuka Kiyo; 1970 Feb; 65(1):51-61. PubMed ID: 4321317 [No Abstract] [Full Text] [Related]
32. [Synacthen depot in the treatment of some dermatological diseases]. Mazurkiewicz W; D abrowska H Przegl Dermatol; 1972; 59(3):377-82. PubMed ID: 4340580 [No Abstract] [Full Text] [Related]
33. [Inhalation therapy of the asthmatic syndrome using salbutamol as an aerosol. Clinical and experimental studies]. Simon E; Loos M Fortschr Med; 1972 Nov; 90(32):1203-6. PubMed ID: 4658477 [No Abstract] [Full Text] [Related]
34. Treatment of bronchial asthma with synthetic long-term corticotrophin. Anderson E; Lorenzen J Scand J Respir Dis Suppl; 1970; 72():127. PubMed ID: 4320311 [No Abstract] [Full Text] [Related]
35. Long-term corticosteroid therapy in chronic intractable asthmatic patients. Tuft L; Marks AD; Channick BJ Ann Allergy; 1971 Jun; 29(6):287-93. PubMed ID: 5560835 [No Abstract] [Full Text] [Related]
36. [Therapy of bronchial asthma with synthetic delayed-action corticotropin]. Andersson E; Lorenzen J Nord Med; 1968 Aug; 80(32):1050-2. PubMed ID: 4301738 [No Abstract] [Full Text] [Related]
37. [Water-electrolyte balance indices in the asthmatic state]. Muradov MK; Erkaev RM Anesteziol Reanimatol; 1977; (5):46-8. PubMed ID: 920982 [No Abstract] [Full Text] [Related]
39. Elimination of severe height growth suppression caused by treatment with betamethasone after switching to ACTH-depot in chronic bronchial asthma. Moulaert AJ; Van Gemund JJ Helv Paediatr Acta; 1972 Apr; 21(1):55-62. PubMed ID: 4336638 [No Abstract] [Full Text] [Related]
40. Betamethasone valerate aerosol in asthmatic patients receiving long-term oral steroid therapy: double-blind controlled trial and follow-up of patients for 20 months. El-Shaboury AH; Williams DA Postgrad Med J; 1974 Sep; 50 suppl 4():15-7. PubMed ID: 4377457 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]